Alcon (NYSE:ALC) announced today that it launched the first and only non-diffractive extended depth of focus intraocular lens in the U.S.
Geneva, Switzerland-based Alcon’s AcrySof IQ Vivity IOL, a presbyopia-mitigating lens, is now available to all U.S. ophthalmologists for use with patients who are undergoing cataract surgery, according to a news release.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,